enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: DEF 14A
Filing Date: 08 May 2026Report Date: 09 Jun 2026
Accepted: 08 May 2026 02:06 p.m.
Accession Number: 0001140361-26-020024
File Number: 001-41854
Film Number: 26958270
Documents
Primary Document: DEF 14A
Accepted: 08 May 2026 02:06 p.m.
0001140361-26-020024-index-headers.html
Last Modified: 08 May 2026 02:06 p.m.
0001140361-26-020024-index.html
Last Modified: 08 May 2026 02:06 p.m.
0001140361-26-020024.txt
Last Modified: 08 May 2026 02:06 p.m.
0001140361-26-020024-xbrl.zip
Last Modified: 08 May 2026 02:06 p.m.
ef20072046_def14a_htm.xml
Last Modified: 08 May 2026 02:06 p.m.
engn-20260609.xsd
Last Modified: 08 May 2026 02:06 p.m.
engn-20260609_lab.xml
Last Modified: 08 May 2026 02:06 p.m.
engn-20260609_pre.xml
Last Modified: 08 May 2026 02:06 p.m.
FilingSummary.xml
Last Modified: 08 May 2026 02:06 p.m.
image00004.jpg
Last Modified: 08 May 2026 02:06 p.m.
image01.jpg
Last Modified: 08 May 2026 02:06 p.m.
MetaLinks.json
Last Modified: 08 May 2026 02:06 p.m.
proxy2.jpg
Last Modified: 08 May 2026 02:06 p.m.
R1.htm
Last Modified: 08 May 2026 02:06 p.m.
R2.htm
Last Modified: 08 May 2026 02:06 p.m.
R3.htm
Last Modified: 08 May 2026 02:06 p.m.
report.css
Last Modified: 08 May 2026 02:06 p.m.
Show.js
Last Modified: 08 May 2026 02:06 p.m.